Pinnacle Associates’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-43,975
| Closed | -$161K | – | 804 |
|
|
2021
Q3 | $161K | Sell |
43,975
-2,000
| -4% | -$7.44K | ﹤0.01% | 745 |
|
|
2021
Q2 | $186K | Buy |
45,975
+625
| +1% | +$2.45K | ﹤0.01% | 742 |
|
|
2021
Q1 | $195K | Hold |
45,350
| – | – | ﹤0.01% | 711 |
|
|
2020
Q4 | $179K | Hold |
45,350
| – | – | ﹤0.01% | 684 |
|
|
2020
Q3 | $167K | Buy |
45,350
+1,000
| +2% | +$4.22K | ﹤0.01% | 651 |
|
|
2020
Q2 | $151K | Buy |
+44,350
| New | +$99.3K | ﹤0.01% | 646 |
|
|
2019
Q4 | – | Sell |
-19,100
| Closed | -$40K | – | 729 |
|
|
2019
Q3 | $40K | Sell |
19,100
-1,000
| -5% | -$2.04K | ﹤0.01% | 696 |
|
|
2019
Q2 | $49K | Buy |
20,100
+1,000
| +5% | +$2.18K | ﹤0.01% | 698 |
|
|
2019
Q1 | $50K | Sell |
19,100
-1,000
| -5% | -$3.03K | ﹤0.01% | 707 |
|
|
2018
Q4 | $61K | Sell |
20,100
-500
| -2% | -$1.7K | ﹤0.01% | 677 |
|
|
2018
Q3 | $71K | Buy |
20,600
+1,250
| +6% | +$6.64K | ﹤0.01% | 696 |
|
|
2018
Q2 | $91K | Sell |
19,350
-16,300
| -46% | -$61.8K | ﹤0.01% | 686 |
|
|
2018
Q1 | $113K | Sell |
35,650
-8,300
| -19% | -$33.4K | ﹤0.01% | 666 |
|
|
2017
Q4 | $215K | Sell |
43,950
-1,400
| -3% | -$8.12K | ﹤0.01% | 632 |
|
|
2017
Q3 | $311K | Sell |
45,350
-4,650
| -9% | -$29.3K | 0.01% | 567 |
|
|
2017
Q2 | $329K | Buy |
50,000
+397
| +0.8% | +$2.78K | 0.01% | 560 |
|
|
2017
Q1 | $397K | Buy |
49,603
+1,800
| +4% | +$15.2K | 0.01% | 521 |
|
|
2016
Q4 | $445K | Sell |
47,803
-2,547
| -5% | -$26.4K | 0.01% | 498 |
|
|
2016
Q3 | $533K | Buy |
50,350
+50
| +0.1% | +$498 | 0.01% | 470 |
|
|
2016
Q2 | $470K | Buy |
50,300
+800
| +2% | +$8.12K | 0.01% | 473 |
|
|
2016
Q1 | $514K | Buy |
49,500
+700
| +1% | +$6.39K | 0.01% | 450 |
|
|
2015
Q4 | $490K | Buy |
48,800
+17,500
| +56% | +$175K | 0.01% | 464 |
|
|
2015
Q3 | $263K | Buy |
31,300
+14,300
| +84% | +$189K | 0.01% | 549 |
|
|
2015
Q2 | $273K | Sell |
17,000
-2,500
| -13% | -$38.9K | 0.01% | 559 |
|
|
2015
Q1 | $276K | Buy |
19,500
+8,000
| +70% | +$104K | 0.01% | 563 |
|
|
2014
Q4 | $115K | Sell |
11,500
-14,000
| -55% | -$120K | ﹤0.01% | 605 |
|
|
2014
Q3 | $217K | Sell |
25,500
-500
| -2% | -$4.39K | ﹤0.01% | 579 |
|
|
2014
Q2 | $230K | Buy |
26,000
+16,000
| +160% | +$140K | ﹤0.01% | 558 |
|
|
2014
Q1 | $93K | Buy |
+10,000
| New | +$87.7K | ﹤0.01% | 587 |
|
Other funds holding OPK
OIM
Pinnacle Associates's OPK Position: Q4 2021 in Review
Pinnacle Associates sold out of Opko Health (OPK) in Q4 2021, closing a stake of 43,975 shares — an estimated $161K sold.
Pinnacle Associates first reported a position in OPK in Q1 2014 and held it in 29 quarters. The position peaked at $533K in Q3 2016. 236 funds tracked by Wall St. Rank hold OPK as of Q4 2021.
- Pinnacle Associates reported no remaining Opko Health position as of Q4 2021 after selling out during the quarter.
- Pinnacle Associates sold 43,975 Opko Health shares in Q4 2021, an estimated $161K.
- Pinnacle Associates first reported a position in Opko Health in Q1 2014 and held it in 29 quarters.
- Pinnacle Associates's Opko Health position peaked at $533K in Q3 2016.
- 236 funds tracked by Wall St. Rank held Opko Health as of Q4 2021.
Based on Pinnacle Associates's 13F filing for Q4 2021, filed 2 Feb 2022.